NEW YORK (GenomeWeb) – The COPD Foundation-sponsored COPD Biomarker Qualification Consortium (CBQC) said today that it has partnered with diagnostics and biotech manufacturer Bio-Techne to evaluate and qualify a serum-based predictive biomarker for selecting subjects for emphysema clinical trials.

The marker, the soluble form of receptor for advanced glycation end products (sRAGE), has shown promise in scientific studies as an indicator of the presence and/or progression of emphysema, the consortium said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Nov
27
Sponsored by
Genialis & Roche

While next-generation sequencing (NGS) has driven recent advances in precision oncology research, it often falls short when identifying the molecular mechanisms underlying many malignancies. As a result, alternative NGS-based approaches are needed to identify oncogenic drivers and potential drug targets.